Stocktoria

Shattuck Labs, Inc. STTK

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-10-09

Shattuck Labs, Inc. statistics & valuation

Market cap$582.0M
P / B7.1×
Net margin-4880.9%
FCF margin-3995.3%
Return on capital-61.3%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-242.60% -368.50% -149.80% -15635.70% -5268.40% -1318.10% -4880.90% 2019202020212022202320242025
Gross margin (%)
2019202020212022202320242025
Operating margin (%)
-253.50% -371.80% -150.80% -15848.00% -5549.60% -1408.30% -5150.80% 2019202020212022202320242025
Return on equity (%)
-11.80% -16.50% -57.90% -60.30% -94.70% -59.20% 2019202020212022202320242025
Shares outstanding
7.6M 41.8M 42.3M 42.4M 47.3M 50.8M 69.6M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-53.30% -10.50% -15.10% -49.70% -54.70% -82.80% -53.60% 2019202020212022202320242025
Free cash flow margin (%)
-216.90% -346.10% -216.70% -16274.80% -4926.70% -1058.80% -3995.30% 2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$2.36 -$1.07 -$2.41 -$2.05 -$1.49 -$0.70 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin-5150.8%-1408.3%-5549.6%-15848.0%-150.8%-371.8%-253.5%
Net margin-4880.9%-1318.1%-5268.4%-15635.7%-149.8%-368.5%-242.6%
FCF margin-3995.3%-1058.8%-4926.7%-16274.8%-216.7%-346.1%-216.9%
Return on assets-53.6%-82.8%-54.7%-49.7%-15.1%-10.5%-53.3%
Return on equity-59.2%-94.7%-60.3%-57.9%-16.5%-11.8%69.4%
Current ratio11.708.8812.517.3911.7220.532.12

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.